Clinical Trials
Phesi Powers Data-Driven Clinical Trials Through Addition of New Country Selection Functionality to ClinSite
Phesi, a data-driven provider of clinical development analytics products and solutions, announced a new country selection functionality has been added to ClinSite, its platform to provide investigator site intelligence to clients, enabling investigator site selection and management. The new...
News
Toppan Subsidiary Okapi Pharmacy Launches Medicine Delivery Service
Okapi Pharmacy, a wholly-owned subsidiary of Toppan Printing, a global leader in communication, security, packaging, décor materials, and electronics solutions, has announced the launch of Todokusuri EXPRESS, a service for delivering prescription medicines to patients through Todokusuri Yakkyoku, a...
News
YoSync Collaborates with IIIT Bangalore to Launch India’s First-Ever COVID-19 Blockchain Platform, BelYo
YoSync, a startup incubated at IIITB-IMACX Studios, signed a research collaboration in agreement with IIIT Bangalore, to partner with BelfricsBT, a Malaysian based blockchain startup. The partnership is aimed at jointly developing a blockchain platform for COVID-19. The project...
News
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of its COVID 19 vaccine with and without Matrix M™ adjuvant in healthy adults...
News
Sharp acquires stake in Berkshire Sterile Manufacturing
Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has purchased a minority ownership in Berkshire Sterile Manufacturing (BSM).
Sharp has taken a minority 25% ownership in BSM with the support of UDG...
News
DHL Global forwarding supports Kuwait’s fight against Covid-19
DHL’s global network and expertise in handling humanitarian logistics provide uninterrupted supply of essential COVID-19 medical supplies to Kuwait’s frontline health workers
Over the course of two months, DHL Global Forwarding, the leading international provider of air, sea and road...
News
Lupin Launches Favipiravir Drug Covihalt for Treatment of Mild to Moderate COVID-19
Pharma major Lupin Limited (Lupin) announced the launch of its Favipiravir in India under the brand name Covihalt® for the treatment of mild to moderate COVID-19. Favipiravir has received authorization from the Drug Controller General of India (DCGI) for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.















